Cite
Strigun A, Wahrheit J, Beckers S, et al. Metabolic profiling using HPLC allows classification of drugs according to their mechanisms of action in HL-1 cardiomyocytes. Toxicol Appl Pharmacol. 2011;252(2):183-91doi: 10.1016/j.taap.2011.02.008.
Strigun, A., Wahrheit, J., Beckers, S., Heinzle, E., & Noor, F. (2011). Metabolic profiling using HPLC allows classification of drugs according to their mechanisms of action in HL-1 cardiomyocytes. Toxicology and applied pharmacology, 252(2), 183-91. https://doi.org/10.1016/j.taap.2011.02.008
Strigun, Alexander, et al. "Metabolic profiling using HPLC allows classification of drugs according to their mechanisms of action in HL-1 cardiomyocytes." Toxicology and applied pharmacology vol. 252,2 (2011): 183-91. doi: https://doi.org/10.1016/j.taap.2011.02.008
Strigun A, Wahrheit J, Beckers S, Heinzle E, Noor F. Metabolic profiling using HPLC allows classification of drugs according to their mechanisms of action in HL-1 cardiomyocytes. Toxicol Appl Pharmacol. 2011 Apr 15;252(2):183-91. doi: 10.1016/j.taap.2011.02.008. Epub 2011 Feb 12. PMID: 21320520.
Copy
Download .nbib